Neurology:TIA和轻型卒中患者非住院治疗的现状和预后

2016-04-06 phylis 译 MedSci原创

目的:评估入院患者和急诊(ED)出院的TIA或轻微卒中患者治疗和预后的差异。方法:研究者应用Ontario卒中登记记录,选取加拿大,Ontario省,2008年4月1日到2009年3月31间轻微的缺血性脑卒中或TIA入院的患者。研究者比较入院和无卒中干预出院及进行卒中干预出院患者的治疗和预后(死亡或再发卒中/ TIA)。结果:共有8540名患者,应用推荐干预措施的入院患者最多,其次是进行卒中干预的

目的:评估住院治疗和急诊(ED)不住院治疗的TIA或轻型卒中患者的治疗和预后的差异。

方法:加拿大的研究者应用Ontario卒中登记记录,选取了加拿大安大略省,2008年4月1日到2009年3月31间轻型缺血性脑卒中或TIA入院的患者。研究者比较住院治疗和无卒中干预急诊不住院治疗及进行卒中干预急诊不住院治疗的患者的治疗和预后(死亡或再发卒中/ TIA)。

结果:共有8540名患者,应用推荐干预措施的住院患者最多,其次是进行卒中干预的急诊不住院患者,最少的是无临床转诊的急诊不住院患者。8%的非住院患者因再发卒中/TIA,一周内再入院。住院和急诊不住院患者中,一年的卒中病死率是相似的(校正HR:1.11;95%CI:0.92-1.34)。从ED出院的患者,进行卒中干预与死亡率降低相关(校正HR: 0.49;95%CI: 0.38-0.64)。

结论:轻型缺血性卒中或TIA患者,住院比急诊不住院更能及时进行卒中治疗。在出院患者中,卒中干预与治疗的改善及死亡率的下降相关。在未来需要相应的措施,改善TIA不住院治疗的质量。

原文出处:

Kapral MK, Hall R, et al.  Association between hospitalization and care after transient ischemic attack or minor stroke. Neurology. 2016 Mar 25.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999671, encodeId=1fbd19996e161, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Aug 23 10:02:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747665, encodeId=b5a81e47665ef, content=<a href='/topic/show?id=ed7d935940d' target=_blank style='color:#2F92EE;'>#轻型卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93594, encryptionId=ed7d935940d, topicName=轻型卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=002835934077, createdName=tcm111hq, createdTime=Wed Feb 15 23:02:00 CST 2017, time=2017-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720103, encodeId=5ddd1e20103ad, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Sat Sep 03 06:02:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-08-23 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999671, encodeId=1fbd19996e161, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Aug 23 10:02:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747665, encodeId=b5a81e47665ef, content=<a href='/topic/show?id=ed7d935940d' target=_blank style='color:#2F92EE;'>#轻型卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93594, encryptionId=ed7d935940d, topicName=轻型卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=002835934077, createdName=tcm111hq, createdTime=Wed Feb 15 23:02:00 CST 2017, time=2017-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720103, encodeId=5ddd1e20103ad, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Sat Sep 03 06:02:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999671, encodeId=1fbd19996e161, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Aug 23 10:02:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747665, encodeId=b5a81e47665ef, content=<a href='/topic/show?id=ed7d935940d' target=_blank style='color:#2F92EE;'>#轻型卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93594, encryptionId=ed7d935940d, topicName=轻型卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=002835934077, createdName=tcm111hq, createdTime=Wed Feb 15 23:02:00 CST 2017, time=2017-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720103, encodeId=5ddd1e20103ad, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Sat Sep 03 06:02:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]

相关资讯

Neurology:TIA或卒中后,Lp-PLA2-A增高会增加短期血管事件

目的:调查TIA或轻微卒中患者急性期脂蛋白相关磷脂酶A2(Lp-PLA2)与短期血管事件再发风险的关系。方法:研究人员从CHANCE(氯吡格雷在急性非致残性脑血管事件高危患者中的应用)试验中招募的3201名受试者Lp-PLA2活性(Lp-PLA2-A)。招募症状开始在24h内TIA或轻微卒中的受试者,并将其随机进行单一或者联合抗血小板治疗。在最近的分析中,主要预后为90天内发生缺血性卒中,心肌梗死